tiprankstipranks
Arecor Therapeutics PLC (GB:AREC)
:AREC
UK Market

Arecor Therapeutics PLC (AREC) Income Statement

Compare
3 Followers

Arecor Therapeutics PLC Income Statement

Last quarter (Q2 2024), Arecor Therapeutics PLC's total revenue was £2.00M, an increase of 139.07% from the same quarter last year. In Q2, Arecor Therapeutics PLC's net income was £-4.64M. See Arecor Therapeutics PLC’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
£ 4.57M£ 2.40M£ 1.16M£ 1.70M£ 1.89M
Gross Profit
£ 4.57M£ 2.06M£ 1.16M£ 1.70M£ 1.89M
Operating Expenses
£ 13.75M£ 13.03M£ 7.13M£ 5.13M£ 4.58M
Depreciation and Amortization
£ 496.00K£ 341.00K£ 171.00K£ 168.00K£ 77.28K
EBITDA
£ -8.39M£ -10.06M£ -6.27M£ -3.26M£ -2.61M
Operating Income
£ -9.18M£ -10.63M£ -5.98M£ -3.43M£ -2.69M
Other Income/Expenses
£ 274.00K£ 88.00K£ -506.00K£ -84.00K£ -3.66K
Pretax Income
£ -8.90M£ -10.54M£ -6.95M£ -3.51M£ -2.69M
Net Income
£ -8.55M£ -9.26M£ -6.17M£ -2.75M£ -2.19M
Per Share Metrics
Basic EPS
£ -0.28£ -0.32£ -0.27£ -0.10£ -0.14
Diluted EPS
£ -0.28£ -0.32£ -0.27£ -0.10£ -0.14
Weighted Average Shares Outstanding
30.62M 28.94M 23.03M 27.68M 15.77M
Weighted Average Shares Outstanding (Diluted)
30.62M 28.94M 23.03M 27.68M 15.77M
Currency in GBP

Arecor Therapeutics PLC Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis